SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554757-13-000346
Filing Date
2013-05-21
Accepted
2013-05-20 20:31:45
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 tapimmune_10q.htm 10-Q 374564
2 CERTIFICATION ex31-1.htm EX-31.1 7847
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex32-1.htm EX-32.1 3198
  Complete submission text file 0001554757-13-000346.txt   2070335

Data Files

Seq Description Document Type Size
4 XBRL PRESENTATION FILE tpiv-20130331_pre.xml EX-101.PRE 67010
5 XBRL INSTANCE FILE tpiv-20130331.xml EX-101.INS 323518
6 XBRL SCHEMA FILE tpiv-20130331.xsd EX-101.SCH 15770
7 XBRL CALCULATION FILE tpiv-20130331_cal.xml EX-101.CAL 16259
8 XBRL DEFINITION FILE tpiv-20130331_def.xml EX-101.DEF 26698
9 XBRL LABEL FILE tpiv-20130331_lab.xml EX-101.LAB 94823
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 13859990
SIC: 2834 Pharmaceutical Preparations